Connective tissue diseases: Belimumab for systemic lupus erythematosus: breaking through?

Nat Rev Rheumatol. 2010 Mar;6(3):124-5. doi: 10.1038/nrrheum.2010.20.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / physiopathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • belimumab